
ARTAN Bio is a longevity biotechnology company headquartered in St. Petersburg, Florida, at spARK Labs by ARK Invest. The company is developing mutation-specific codon suppression technologies to address genetic diseases and aging-related conditions caused by nonsense mutations. ARTAN Bio's platform is designed to deliver engineered suppressor systems through established delivery modalities to restore protein function in affected cells.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/03/26 | $1,000,000 | Seed |
Michael Torres | undisclosed |